C22orf24

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, C22orf24 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated C22orf24 data layer compared with 2 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher C22orf24 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated C22orf24 expression acts as an unfavorable survival marker, although some lineages such as UCS and THYM show a favorable association.

UCS, ACC, and THYM are the cancer types where C22orf24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCSDFSMedianII,III,IV0.4850.127<.001100view →
ACCDFSTertileAll0.2060.678<.00166view →
THYMOSTertileII,III,IV1.0000.512.00232view →
BLCADFSTertileII,III,IV0.2270.393.00932view →
READOSMedianII,III,IV0.7930.422.00321view →
BRCADFSTertileIV0.9130.424.01214view →
SCLCDFSMedianII,III,IV0.7270.458.01213view →
KIRPDFSTertileIII,IV0.8570.384.04012view →
KICHOSMedianII,III,IV1.0000.880.00410view →
SKCMDFSMedianIV0.6330.073.01110view →
LUSCOSMedianIV0.0570.786.0089view →
COADOSMedianAll0.9050.830.0124view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

C22orf24–UCS (DFS)

Kaplan–Meier survival curve for C22orf24 RNA-high vs -low samples in UCS.

Open the UCS breakdown →

Exploration